TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Delayed-Action Preparations/therapeutic use
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Injections, Intramuscular
KW - Male
KW - Naltrexone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Recurrence
AU - A. Opheim
AU - Z. Gaulen
AU - K. K. Solli
AU - Z. E. Latif
AU - L. T. Fadnes
AU - J. S. Benth
AU - N. Kunøe
AU - L. Tanum
A1 - 
AD - Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Institute of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Dentistry, University of Bergen, Bergen, Norway.; Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.; Department of Research and Development in Mental Health Services, University Hospital, Lorenskog, Norway.; Vestfold Hospital Trust, Tonsberg, Norway.; Groruddalen Psychosis Outpatient Department, Akershus University Hospital, Oslo, Norway.; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Institute of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway.; Health Services Research Unit, Akershus University Hospital, Lorenskog, Norway.; Lovisenberg Diaconal Hospital, Oslo, Norway.; Department of Research and Development in Mental Health Services, University Hospital, Lorenskog, Norway.; Faculty for Health Science, Oslo Metropolitan University, Oslo, Norway.
BT - The American journal on addictions
C5 - Education & Workforce; Opioids & Substance Use
CP - 5
CY - England
DO - 10.1111/ajad.13151
IS - 5
JF - The American journal on addictions
LA - eng
M1 - Journal Article
PB - American Academy of Addiction Psychiatry
PP - England
PY - 2021
SN - 1521-0391; 1055-0496
SP - 453
EP - 460
EP - 
T1 - Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
T2 - The American journal on addictions
TI - Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
U1 - Education & Workforce; Opioids & Substance Use
U2 - 34487395
U3 - 10.1111/ajad.13151
VL - 30
VO - 1521-0391; 1055-0496
Y1 - 2021
Y2 - Sep
ER -